Trials / Completed
CompletedNCT05128812
Study of the Effects of Plx on Bioparametric Measurements.
Study of the Anxiolytic Effects, Improvement of Sleep Quality and Bioparametric Measures in Individuals Taking an Extract of Lippia Citriodora.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Alicante · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
The main objective is to study the effects of the intake of a nutraceutical on health indicators, focused on sleep and stress, as well as cardiovascular (blood pressure...), circulating (cortisol) and body composition parameters in a Spanish adult population.
Detailed description
Anxiety is a normal part of life, and generally is a temporary condition. However, anxiety can occasionally prolong in time, having an impact on everyday activities, and give rise to other conditions, such as depression, drug abuse, cardiovascular disease, and insomnia. There are a number of synthetic drugs that are commonly used to treat anxiety. These are mainly antidepressants and benzodiazepines. However, their high cost, important side effects and a rising interest in natural solutions have driven researchers to search for botanical-based formulas. To this end, there are a number of plants that have been described to possess potential sedative and anxiolytic effects. Of note is lemon verbena (Lippia citriodora), which is native of Western South America but is also cultivated in the Mediterranean region and Middle East.
Conditions
- Quality of Life
- Antidepressive Agents
- Depression, Anxiety
- Sleep Initiation and Maintenance Disorders
- Body Composition
- Stress, Psychological
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | PLX | Intake of natural food supplement of vegetable origin based on lemon verbena extract (Lippia citriodora). To study the anxiolytic effects in subjects with high perceived stress levels and low sleep quality. |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2021-07-31
- Completion
- 2022-12-01
- First posted
- 2021-11-22
- Last updated
- 2023-06-09
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05128812. Inclusion in this directory is not an endorsement.